Search Results 1001-1010 of 18964 for Neutrophil

1. Safety and Efficacy Study of MLN0128 in Combination With Exemestane or Fulvestrant in Postmenopausal Women With ER/PR+ Metastatic Breast Cancer - Mayo Clinic

   Bone marrow reserve consistent with absolute neutrophil count (ANC) ≥ 1.5 x 10^9/L; platelet count ≥ 100 x 10^9/L; hemoglobin ≥ 9 g/dL; Total bilirubin ...

2. A Study to Evaluate Non-Operative Management and Early Response Assessment in Rectal Cancer - Mayo Clinic

   - Absolute neutrophil count (ANC) > 1,500 cells/mm3 - Hemoglobin> 8 g/dl - Platelets >100,000 cells/mm3 - Women of childbearing potential and men must agree ...

3. Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1500 cells/L; Platelets ≥ 100,000 u/L; Creatinine ≤ 1.5 x upper limit of normal (ULN); Serum glutamic oxaloacetic ...

4. A Study of the Safety and Drug/Body Interactions of BGB-3111 for Patients with B-Cell Lymphoid Malignancies - Mayo Clinic

   ... neutrophils < 1.0 x 10^9/L due to marrow infiltration are allowed to receive growth factors to bring pre-treatment neutrophils to ≥ 1.0 x 10^9/L. Adequate ...

5. A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1500/mm^3 without the use of hemopoietic growth factors within the last 7 days prior to randomisation;; Platelet count ...

6. A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Crohn's Disease Who Completed the Studies M14-431 or M14-433 - Mayo Clinic

   Absolute neutrophil count (ANC) < 1,000/µL;; Platelet count < 50,000/µL;; Absolute lymphocyte count < 500/µL;; Hemoglobin < 8 g/dL. Enrollment in another ...

7. A Study to Evaluate Ramucirumab Plus Trifluridine/Tipiracil to Treat Patients with Previously-treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma - Mayo Clinic

   * Absolute neutrophil count (ANC) \>= 1500/mm\^3 (obtained =\< 7 days prior to registration) * Platelet count \>= 100,000/mm\^3 (obtained =\< 7 days prior ...

8. A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers - Mayo Clinic

   Absolute neutrophil count ≥ 1000/μL;; Platelet count ≥ 75,000/μL (≥ 30,000/μL if bone marrow plasma cells are ≥ 50% of cellularity for myeloma patients) ...

9. A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP) - Mayo Clinic

   Hematocrit < 35% for males and < 32% for females or absolute neutrophil cell count of < 1500/μL;; Clinically significant abnormal thyroid stimulating hormone ...

10. Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment - Mayo Clinic

    - Absolute neutrophil count ≥ 1,500/mcL. - Platelets ≥ 100,000/mcL. - Hemoglobin ≥ 10 g/dL. - Total bilirubin ≤ 2 x institutional upper limit of normal ...